{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"The propensity to calcify soft tissues will be measured by T50 for 9 months of treatment. T50 is a novel serum-based marker that assesses the propensity of calcification in serum. Shorter T50 indicates greater propensity to calcify.","groups":[{"description":"Every study participant will receive etelcalcetide prescribed by their treating physician for the duration of the study.\n\nEtelcalcetide: Administered intravenously at the end of each dialysis session. Dosing ranges from 5 mg to 15 mg set by the patient's physician.","id":"OG000","title":"Study Participant"}],"populationDescription":"No data, as measured by T50, was collected. Therefore there is no data that can be reported.","reportingStatus":"POSTED","timeFrame":"9 months","title":"Propensity as Measured by T50","type":"PRIMARY"}